Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF11 Telbivudine
D06675 Telbivudine (USAN/INN)
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D06675 Telbivudine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HBV reverse transcriptase inhibitor
D06675 Telbivudine (USAN/INN)
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HBV reverse transcriptase inhibitor
D06675 Telbivudine (USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D06675
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D06675
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D06675
Other DBs
CAS:
3424-98-4
PubChem:
47208326
ChEBI:
63624
PDB-CCD:
LLT[PDBj]
LigandBox:
D06675
KCF data
ATOM 17
1 C1y C 21.6300 -29.5400
2 C1x C 23.0300 -29.5400
3 C1y C 23.4500 -28.2800
4 O2x O 22.3300 -27.4400
5 C1y C 21.2100 -28.2800
6 O1a O 20.7900 -30.6600
7 C1b C 19.8800 -27.8600
8 O1a O 18.8300 -28.7700
9 N4y N 24.6400 -27.5800
10 C8y C 25.9000 -26.8800
11 N4x N 25.9000 -25.4800
12 C8y C 24.7100 -24.7800
13 C8y C 23.4500 -25.4800
14 C8x C 23.4500 -26.8800
15 O5x O 27.1066 -27.5900
16 O5x O 24.7272 -23.3801
17 C1a C 22.2434 -24.7700
BOND 18
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 1 6 1 #Up
7 5 7 1 #Down
8 7 8 1
9 3 9 1 #Down
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 2
15 9 14 1
16 10 15 2
17 12 16 2
18 13 17 1